Investors Notified of Class Action Lawsuits Against Prominent Companies Including MSFT, PERI, SOND, OCGN, and QDEL

New York, June 7, 2024 – Bragar Eagel & Squire, P.C., a shareholder rights advocacy firm, has announced the initiation of class action proceedings on behalf of investors of several high-profile companies. Allegations have surfaced, prompting legal action against entities such as Ocugen, Inc. OCGN, Sonder Holdings Inc. SOND, Perion Network Ltd. PERI, and Quidel Corporation QDEL for various infractions of securities laws. Investors are being urged to contact the firm to participate in the class action suits.

Microsoft Corporation - A Multinational Leader in Technology

Microsoft Corporation MSFT, a global technology giant, continues to make waves with innovative software and hardware solutions. Renowned for its Windows operating system, Office suite, and Internet Explorer and Edge browsers, Microsoft also delights gaming enthusiasts with Xbox consoles, and productivity seekers with the Surface PC range. With impressive rankings, including the Fortune 500 list, and significant revenue as the world's top software maker as of 2016, Microsoft stands as a formidable player among the Big Five of the U.S. tech industry.

Perion Network - Innovating Advertising Globally

Perion Network Ltd. PERI, headquartered in Israel, harnesses its expertise to deliver advanced advertising strategies across North America, Europe, and the international market. The firm's dedication to excellence positions it as a trusted partner to brands, agencies, and publishers looking to navigate the complex digital advertising landscape.

Sonder Holdings - Redefining Hospitality

Sonder Holdings Inc. SOND, with its base in California's tech hub, San Francisco, ventures into the hospitality domain with a fresh perspective. Sonder's innovative approach aims to elevate customer experiences in the ever-evolving hospitality sector.

Ocugen, Inc. - Visionary Biopharmaceuticals

Malvern-based Ocugen, Inc. OCGN, is at the forefront of developing gene therapies aimed at conquering blindness-related diseases. As a clinical-stage biopharmaceutical player, Ocugen's focus on novel treatments highlights its commitment to addressing some of the most challenging medical conditions.

Quidel Corporation - Diagnostic Excellence

Quidel Corporation QDEL, operating globally from San Diego, has carved a niche in the healthcare industry by providing essential diagnostic testing solutions. Quidel's diverse portfolio serves a myriad of health needs, including infectious diseases, cardiology, thyroid, general wellness, and more, enhancing the quality of patient care around the world.

investment, legal, classaction